Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Open this folder and view contents2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Open this folder and view contents5 ADDITIONAL SOURCES OF INFORMATION
Open this folder and view contents6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Open this folder and view contents8 EVALUATION
Open this folder and view contents9 REVIEW AND UPDATE
View the documentREFERENCES
 

REFERENCES

1. Chapter 10. Treatment guidelines and formulary manuals. In: Quick JD et al., eds. Managing drug supply. 2nd ed. New York, Kumarian Press, 1997.

2. The rationale of essential medicines. Geneva, World Health Organization (http://www.who.int/medicines/rationale.shtml).

3. The thirteenth WHO model list of essential medicines. Geneva, World Health Organization, 2003 (http://www.who.int/medicines/organization/par/edl/eml.shtml)

4. Grimshaw JM, et al. Changing provider behavior: an overview of systematic reviews of interventions. Medical Care, 2001, 39(8 Supple 2):II2-45.

5. How to develop and implement a national drug policy, 2nd ed. Geneva, World Health Organization, 2001 (http://www.who.int/medicines/library/par/ndpeng.pdf).

6. The selection and use of essential medicines. Report of a WHO Expert Committee, 2002 (including the 12th Model list of essential medicines). Geneva, World Health Organization, 2003 (WHO Technical Report Series, No. 914) (http://www.who.int/medicines/organization/par/edl/trs/trs914_001to126.pdf).

7. Anonymous. Prescribing information in 26 countries. Geneva, World Health Organization, 2003 (WHO Drug Information Vol. 17, No. 3).

8. Osifo NG. Overpromotion of drugs in international product package inserts. Tropical Doctor 1983, 13:5-8.

9. Mullen WH et al. Incorrect overdose management advice in the Physicians' Desk Reference. Annals of Emergency Medicine, 1997, 29:255-261.

10. Cohen JS. Dose discrepancies between the Physicians' Desk Reference and the medical literature, and their possible role in the high incidence of dose-related adverse drug events. Archives of Internal Medicine, 2001, 161:957-964.

11. Medical products and the Internet - a guide to finding reliable information. Geneva, World Health Organization, 1999 (WHO/EDM/QSM/99.4) (http://www.who.int/medicines/library/qsm/who-edm-qsm-99-4/medicines-on-internet-guide.html).

to previous section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014